Skip to main content
. 2022 May 24;14(6):1118. doi: 10.3390/pharmaceutics14061118

Figure 3.

Figure 3

Biodistribution of 89Zr-labeled GMP-grade exosomes in mice analyzed using ex vivo gamma-counting analysis. (a) Schematic of the ex vivo gamma-counting analysis of the distribution of i.v.-administered 89Zr-Exo in various organs and tissues of mice. (b) Whole-body fraction of 89Zr-Exo in various organs of mice (n = 4 for each time point) was determined using a gamma-counting assay, with the results shown as the %ID at various time points. (c) Time-course distribution of 89Zr-Exo in each organ determined using a gamma-counting assay was shown as the %ID with SEM. (d) Time-course distribution of 89Zr-Exo in the blood, urine, muscle, and femur was shown as the %ID/g with SEM due to differences in the sampling methods.